Open AccessAdjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
Author(s) -
Sara M. Tolaney,
William T. Barry,
Chau T. Dang,
Denise A. Yardley,
Beverly Moy,
P. Kelly Marcom,
Kathy S. Albain,
Hope S. Rugo,
Matthew J. Ellis,
Iuliana Shapira,
Antonio C. Wolff,
Lisa A. Carey,
Beth Overmoyer,
Ann H. Partridge,
Hao Guo,
Clifford A. Hudis,
Ian E. Krop,
Harold J. Burstein,
Eric P. Winer
Publication year - 2015
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/5g5m-fr14
Subject(s) - trastuzumab , paclitaxel , oncology , breast cancer , adjuvant , medicine , cancer